Authors: BALLINGER JR BANNERMAN J BOXEN I FIRBY P HARTMAN NG MOORE MJ

Citation: Jr. Ballinger et al., TECHNETIUM-99M-TETROFOSMIN AS A SUBSTRATE FOR P-GLYCOPROTEIN - IN-VITRO STUDIES IN MULTIDRUG-RESISTANT BREAST-TUMOR CELLS, The Journal of nuclear medicine, 37(9), 1996, pp. 1578-1582

Authors: POLLAK A GOODBODY AE BALLINGER JR DUNCAN GS TRAN LL DUNNDUFAULT R MEGHJI K LAU F ANDREY TW BOXEN I SUMNERSMITH M

Citation: A. Pollak et al., IMAGING INFLAMMATION WITH TC-99(M)-LABELED CHEMOTACTIC PEPTIDES - ANALOGS WITH REDUCED NEUTROPENIA, Nuclear medicine communications, 17(2), 1996, pp. 132-139

Authors: TESIC M SHELDON KM BALLINGER JR BOXEN I

Citation: M. Tesic et al., LABELING SMALL QUANTITIES OF MONOCLONAL-ANTIBODIES AND THEIR F(AB')(2) FRAGMENTS WITH TC-99M, Nuclear medicine and biology, 22(4), 1995, pp. 451-457

Authors: BALLINGER JR HUA HA BERRY BW FIRBY P BOXEN I

Citation: Jr. Ballinger et al., TC-99(M)-SESTAMIBI AS AN AGENT FOR IMAGING P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE - IN-VITRO AND IN-VIVO STUDIES IN A RAT BREAST-TUMOR CELL-LINE AND ITS DOXORUBICIN-RESISTANT VARIANT, Nuclear medicine communications, 16(4), 1995, pp. 253-257

Authors: BALLINGER JR SHELDON K BOXEN I ERLICHMAN C LING V

Citation: Jr. Ballinger et al., ROLE OF P-GLYCOPROTEIN (PGP) IN ACCUMULATION OF TL-201 (TL) AND TC-99M SESTAMIBI (MIBI) IN TUMOR-CELLS, The Journal of nuclear medicine, 34(5), 1993, pp. 242-242